We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Robin Spiller

Prof Robin Spiller MD

Professor of Gastroenterology, NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, United Kingdom

Professor Spiller is Professor of Gastroenterology in the Nottingham Digestive Diseases Centre at the University of Nottingham. He is Past Editor of Gut (2003-2009) and member of the Board of the Rome Foundation (2000-2015), he twice edited the British Society of Gastroenterology (BSG) Guidelines for the management of IBS. His main research interest is the pathophysiology of irritable bowel syndrome(IBS), particularly the role of infection, inflammation, diet and alterations in the microbiome as well as a long standing collaboration with the Sir Peter Mansfield Imaging Centre pioneering the use of MRI to image the underlying mechanisms in functional bowel diseases and how the structure of food alters postprandial small and large intestinal volumes and motility. Author/co-author of more than 388 scientific reviews and original publications. Current studies include an EME funded multicentre trial TReatment of Irritable bowel syndrome with diarrhoea using Titrated ONdansetron (TRITON), RECLAIM a MRC funded study of colonic motility using MRI and High resolution manometry and a Newton grant examining the effect of fibre of intestinal physiology in IBS. 

Disclosures

Professor Spiller has had research grant support from Zespri International and Sanofi-Aventis and has received speakers fees from Alfawasserman.